» Articles » PMID: 36364371

Marine Antimicrobial Peptides-Based Strategies for Tackling Bacterial Biofilm and Biofouling Challenges

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2022 Nov 11
PMID 36364371
Authors
Affiliations
Soon will be listed here.
Abstract

An assemblage nexus of microorganisms enclosed in a composite extracellular polymeric matrix is called as a biofilm. The main factor causing biological fouling, or biofouling, is biofilms. Biofilm-mediated biofouling is a significant detrimental issue in several industries, including the maritime environment, industrial facilities, water treatment facilities, and medical implants. Conventional antibacterial remedies cannot wholly eradicate bacterial species owing to the structural rigidity of biofilm and the eventual growth of antibiotic-resistant microorganisms. Consequently, several approaches to disrupt the biofilm have been investigated to address this particular phenomenon. Antimicrobial peptides (AMPs) have emerged as a promising contender in this category, offering several advantages over traditional solutions, including broad-spectrum action and lack of antibiotic resistance. Because biofouling significantly impacts the marine industry, AMPs derived from marine sources may be suitable natural inhibitors of bacterial proliferation. In this article, we discuss the range of physicochemical and structural diversity and the model of action seen in marine AMPs. This makes them an appealing strategy to mitigate biofilm and biofilm-mediated biofouling. This review also systematically summarizes recent research on marine AMPs from vertebrates and invertebrates and their industrial significance, shedding light on developing even better anti-biofouling materials shortly.

Citing Articles

Antimicrobial proteins from oyster hemolymph improve the efficacy of conventional antibiotics.

Summer K, Guo Q, Liu L, Barkla B, Giles S, Benkendorff K PLoS One. 2025; 20(1):e0312305.

PMID: 39836702 PMC: 11750097. DOI: 10.1371/journal.pone.0312305.


A Comprehensive Review of Recent Research into the Effects of Antimicrobial Peptides on Biofilms-January 2020 to September 2023.

Fontanot A, Ellinger I, Unger W, Hays J Antibiotics (Basel). 2024; 13(4).

PMID: 38667019 PMC: 11047476. DOI: 10.3390/antibiotics13040343.


Antibiofilm activity of marine microbial natural products: potential peptide- and polyketide-derived molecules from marine microbes toward targeting biofilm-forming pathogens.

Sukmarini L, Atikana A, Hertiani T J Nat Med. 2023; 78(1):1-20.

PMID: 37930514 DOI: 10.1007/s11418-023-01754-2.


Bio-Inspired Nanomaterials for Micro/Nanodevices: A New Era in Biomedical Applications.

Harun-Ur-Rashid M, Jahan I, Foyez T, Imran A Micromachines (Basel). 2023; 14(9).

PMID: 37763949 PMC: 10536921. DOI: 10.3390/mi14091786.


Membrane-Active Peptides and Their Potential Biomedical Application.

Gostaviceanu A, Gavrilas S, Copolovici L, Copolovici D Pharmaceutics. 2023; 15(8).

PMID: 37631305 PMC: 10459175. DOI: 10.3390/pharmaceutics15082091.


References
1.
Daletos G, Kalscheuer R, Koliwer-Brandl H, Hartmann R, de Voogd N, Wray V . Callyaerins from the Marine Sponge Callyspongia aerizusa: Cyclic Peptides with Antitubercular Activity. J Nat Prod. 2015; 78(8):1910-25. DOI: 10.1021/acs.jnatprod.5b00266. View

2.
Anju A, Smitha C, Preetha K, Boobal R, Rosamma P . Molecular characterization, recombinant expression and bioactivity profile of an antimicrobial peptide, Ss-arasin from the Indian mud crab, Scylla serrata. Fish Shellfish Immunol. 2019; 88:352-358. DOI: 10.1016/j.fsi.2019.03.007. View

3.
Lohner K, Prossnigg F . Biological activity and structural aspects of PGLa interaction with membrane mimetic systems. Biochim Biophys Acta. 2009; 1788(8):1656-66. DOI: 10.1016/j.bbamem.2009.05.012. View

4.
Wang G, Li X, Wang Z . APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 2015; 44(D1):D1087-93. PMC: 4702905. DOI: 10.1093/nar/gkv1278. View

5.
Kang H, Seo C, Park Y . Marine peptides and their anti-infective activities. Mar Drugs. 2015; 13(1):618-54. PMC: 4306955. DOI: 10.3390/md13010618. View